Estudo randomizado: Vacina da Pfizer-BioNTech contra Covid-19 mostrou 100% de eficácia em adolescentes – Foi observada sobretudo reatogenicidade transitória, de leve a moderada, como dor no local da injeção (em 79 a 86% dos participantes), fadiga (em 60 a 66%) e cefaleia (em 55 a 65%).

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents – New England Journal of Medicine

Relacionado: [Press release – not published yet] Pfizer-BioNTech vaccine 100% effective against Covid-19 in adolescents

Comentário no Twitter

The 12-15 year-olds mRNA vaccine randomized, placebo-controlled clinical trial is published @NEJM today [@BioNTech_Group/@Pfizer]https://t.co/7GlgC9xdd0
—100% efficacy (95% CI 75,100)
—1.8 X higher levels of neutralizing antibodies than 16-25 yr olds
—very good safety profile pic.twitter.com/hQzkpuA5Nu

— Eric Topol (@EricTopol) May 27, 2021